Memantine Hydrochloride Tablet
Product Images NDC 68788-8647

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 68788-8647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-figure1 (Memantine Figure1)

A line graph showing mean change from baseline in ADCS-ADL score over 28 weeks of treatment comparing Memantine Hydrochloride tablets 10 mg with placebo. The x-axis represents weeks of treatment, and the y-axis shows mean change with error bars. Separate lines represent placebo and Memantine Hydrochloride, illustrating different clinical outcomes.*

FDA Label Image

Memantine-figure3 (Memantine Figure3)

A line graph showing the mean change from baseline in SIB score over 28 weeks of treatment comparing Memantine Hydrochloride and placebo. The graph depicts clinical improvement and decline zones, with Memantine Hydrochloride maintaining near baseline scores and placebo showing a decline.*

FDA Label Image

Memantine-figure5 (Memantine Figure5)

A line graph displaying the mean change from baseline in the ADCS-ADL score over 24 weeks of treatment, comparing Memantine Hydrochloride/Donepezil versus Placebo/Donepezil. The x-axis represents weeks of treatment, and the y-axis shows mean change with error bars. The graph indicates clinical improvement and decline thresholds.*

FDA Label Image

Memantine-figure7 (Memantine Figure7)

A line graph showing mean change from baseline in SIB Score over 24 weeks of treatment. The graph compares two groups: Placebo/Donepezil (black squares) and Memantine Hydrochloride/Donepezil (white circles). The Memantine Hydrochloride/Donepezil group shows a clinical improvement trend, while the Placebo/Donepezil group shows clinical decline over time. Error bars represent ± SEM.*

FDA Label Image

Memantine_structure (Memantine Structure)

Chemical structure of Memantine Hydrochloride showing its bicyclic amine framework with an amino group bonded to hydrochloride.*

FDA Label Image

Memantine HCl Tablets 10mg (Memantine 10mg)

Memantine Hydrochloride Tablets 10 mg label from Preferred Pharmaceuticals Inc. The label includes dosage directions in English and Spanish, a barcode, and storage instructions. Manufacturer is Ajanta Pharma Limited. The label highlights the drug name, strength, and warnings such as storing at controlled room temperature and keeping out of reach of children.*

FDA Label Image

Memantine-figure2 (Memantine Figure2)

A line graph showing cumulative percentage of patients on the y-axis versus ADCS-ADL change from baseline on the x-axis. The graph compares two groups: placebo (square markers) and Memantine hydrochloride (circular markers), indicating different response distributions between the two treatments.*

FDA Label Image

Memantine-figure4 (Memantine Figure4)

A line graph showing the cumulative percentage of patients on the vertical axis versus SIB change from baseline on the horizontal axis. Two curves compare placebo and memantine hydrochloride treatment, depicting patient response over a range of SIB changes.*

FDA Label Image

Memantine-figure6 (Memantine Figure6)

A cumulative percentage of patients chart depicting ADCS-ADL change from baseline on the horizontal axis and cumulative percentage on the vertical axis. The graph compares placebo/Donepezil with Memantine hydrochloride/Donepezil, showing performance distributions for these groups.*

FDA Label Image

Memantine-figure8 (Memantine Figure8)

A cumulative percentage plot comparing patient responses by SIB change from baseline for Memantine hydrochloride/Donepezil versus Placebo/Donepezil, showing cumulative percentages of patients on the y-axis and SIB change on the x-axis ranging from -30 to 20.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.